Literature DB >> 10543352

The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study.

C Laske1, O Gefeller, A Pfahlberg, I Zerr, A Schröter, S Poser.   

Abstract

The association between Creutzfeldt-Jakob disease (CJD) and stressful life events was examined in a pilot case-control study in Germany. The study sample consisted of 37 CJD cases and 37 controls, both groups were frequency-matched for age and sex. In standardised interviews of close relatives of the cases and the controls, all stressful life events were assessed and subsequently grouped into one of the following three subgroups: psychosocial stress events, medical operations with hospitalisation, and other serious medical examinations. A significantly higher proportion of CJD cases experienced stressful life events during the last six months before disease onset than controls (65% vs. 32%, p = 0.01), yielding an odds ratio (OR) of 3.85 (95% confidence interval (CI): 1.33-11.30). We found the clearest distinction between cases and controls for the subgroup of medical operations where an OR of 6.97 (95% CI: 0.76-329.20) was observed. Further data indicated that stressful events seem to influence not only the onset of CJD but also the progression of the disease. Although based on a rather small study sample, this pilot case-control investigation suggests evidence that stressful life events in the last six months before disease onset may influence CJD occurrence and may modify the course of disease. This 'stress hypothesis', which is in line with findings from other epidemiological and experimental studies in CJD, is thus a promising direction for future CJD research as it could enlighten the pathophysiological mechanisms and point towards strategies for the prevention and therapy of CJD.

Entities:  

Mesh:

Year:  1999        PMID: 10543352     DOI: 10.1023/a:1007683208121

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Creutzfeldt-Jakob disease and stress.

Authors:  J P Brandel; N Delasnerie-Laupretre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

Review 2.  Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials.

Authors:  R A Gadient; U H Otten
Journal:  Prog Neurobiol       Date:  1997-08       Impact factor: 11.685

3.  Incidence of Creutzfeldt-Jakob disease in Europe in 1993.

Authors:  A Alperovitch; P Brown; T Weber; M Pocchiari; A Hofman; R Will
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321

4.  A case control study of Creutzfeldt-Jakob disease: association with physical injuries.

Authors:  K Kondo; Y Kuroiwa
Journal:  Ann Neurol       Date:  1982-04       Impact factor: 10.422

5.  Statistical methods in cancer research. Volume I - The analysis of case-control studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1980

6.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

7.  Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering.

Authors:  C L Masters; J O Harris; D C Gajdusek; C J Gibbs; C Bernoulli; D M Asher
Journal:  Ann Neurol       Date:  1979-02       Impact factor: 10.422

8.  Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat.

Authors:  J K Relton; N J Rothwell
Journal:  Brain Res Bull       Date:  1992-08       Impact factor: 4.077

9.  Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).

Authors:  C M van Duijn; N Delasnerie-Lauprêtre; C Masullo; I Zerr; R de Silva; D P Wientjens; J P Brandel; T Weber; V Bonavita; M Zeidler; A Alpérovitch; S Poser; E Granieri; A Hofman; R G Will
Journal:  Lancet       Date:  1998-04-11       Impact factor: 79.321

10.  Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease.

Authors:  I Zerr; M Bodemer; S Räcker; S Grosche; S Poser; H A Kretzschmar; T Weber
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

View more
  4 in total

1.  Towards an age-dependent transmission model of acquired and sporadic Creutzfeldt-Jakob disease.

Authors:  Jesús de Pedro-Cuesta; Ignacio Mahillo-Fernandez; Miguel Calero; Alberto Rábano; Mabel Cruz; Åke Siden; Pablo Martínez-Martín; Henning Laursen; María Ruiz-Tovar; Kåre Mølbak
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

Review 2.  Risk of transmission of sporadic Creutzfeldt-Jakob disease by surgical procedures: systematic reviews and quality of evidence.

Authors:  Fernando J García López; María Ruiz-Tovar; Javier Almazán-Isla; Enrique Alcalde-Cabero; Miguel Calero; Jesús de Pedro-Cuesta
Journal:  Euro Surveill       Date:  2017-10

3.  Late-in-life surgery associated with Creutzfeldt-Jakob disease: a methodological outline for evidence-based guidance.

Authors:  Mabel Cruz; Ignacio Mahillo-Fernandez; Alberto Rábano; Ake Siden; Miguel Calero; Henning Laursen; Kåre Mølbak; Javier Almazán; Jesus de Pedro-Cuesta
Journal:  Emerg Themes Epidemiol       Date:  2013-05-23

4.  A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001-2004.

Authors:  Jessica Ruegger; Katharina Stoeck; Lorenz Amsler; Thomas Blaettler; Marcel Zwahlen; Adriano Aguzzi; Markus Glatzel; Klaus Hess; Tobias Eckert
Journal:  BMC Public Health       Date:  2009-01-14       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.